↓ Skip to main content

Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin

Overview of attention for article published in Molecular Cancer Therapeutics, May 2008
Altmetric Badge

Mentioned by

patent
11 patents

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin
Published in
Molecular Cancer Therapeutics, May 2008
DOI 10.1158/1535-7163.mct-07-2256
Pubmed ID
Authors

Andrea Newbold, Ralph K. Lindemann, Leonie A. Cluse, Kate F. Whitecross, Anthony E. Dear, Ricky W. Johnstone

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
China 1 3%
Unknown 31 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 38%
Student > Doctoral Student 3 9%
Researcher 3 9%
Student > Postgraduate 3 9%
Student > Bachelor 2 6%
Other 3 9%
Unknown 6 19%
Readers by discipline Count As %
Agricultural and Biological Sciences 10 31%
Medicine and Dentistry 7 22%
Biochemistry, Genetics and Molecular Biology 3 9%
Immunology and Microbiology 2 6%
Nursing and Health Professions 1 3%
Other 3 9%
Unknown 6 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2017.
All research outputs
#7,483,725
of 22,875,477 outputs
Outputs from Molecular Cancer Therapeutics
#1,673
of 3,864 outputs
Outputs of similar age
#28,355
of 82,050 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#23
of 55 outputs
Altmetric has tracked 22,875,477 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,864 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 82,050 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.